Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

CompletedOBSERVATIONAL
Enrollment

2,334

Participants

Timeline

Start Date

December 17, 2014

Primary Completion Date

April 5, 2017

Study Completion Date

April 5, 2017

Conditions
Acute Coronary Syndromes
Trial Locations (33)

Unknown

Research Site, Baoding

Research Site, Beijing

Research Site, Changzhi

Research Site, Chongqing

Research Site, Guangzhou

Research Site, Guiyang

Research Site, Haerbin

Research Site, Hangzhou

Research Site, Hebei

Research Site, Jilin

Research Site, Jinan

Research Site, Jinzhong

Research Site, Kunming

Research Site, Lanzhou

Research Site, Nanjing

Research Site, Nanning

Research Site, Shanghai

Research Site, Shenyang

Research Site, Shenzhen

Research Site, Shihezi

Research Site, Taiyuan

Research Site, Tangshan

Research Site, Tianjin

Research Site, Ürümqi

Research Site, Wuhan

Research Site, Wuxi

Research Site, Xi'an

Research Site, Xining

Research Site, Xuzhou

Research Site, Yinchuan

Research Site, Yulin

Research Site, Zhengzhou

Research Site, Zhenjiang

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY